This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus.
A one-two punch of powerful antibodies may be the best way to stop Ebola virus, reports an international team of scientists in the journal Cell. Their findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.
“This study presents results from an unprecedented international collaboration and demonstrates how 43 previously competing labs can together accelerate therapeutics and vaccine design,” says Erica Ollmann Saphire, PhD, professor at Scripps Research and director of the Viral Hemorrhagic Fever Immunotherapeutic Consortium (VIC).
From 2013–2016, West Africa faced the deadliest Ebola outbreak the world has ever seen. By the time the outbreak was declared over, 11,325 people had died. The VIC is an international group of the world’s leading virologists, immunologists, systems biologists and structural biologists working to stop an outbreak on that scale from ever striking again.
The VIC researchers aim to understand which Ebola-fighting antibodies are best—and why. The hope is that the most effective antibodies can be combined in a therapeutic “cocktail.” Unlike an Ebola vaccine, these cocktails could be given to those already infected, which is important for stopping a disease that tends to emerge unexpectedly in remote locations.
Ollmann Saphire and her colleagues in the VIC have published more than 40 studies in just the last five years. This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus and other related viruses, known as filoviruses. All antibodies in the panel were donated by different labs around the world, and many had not been previously characterized in such extensive detail.
“Through the VIC, we could test a larger pool of antibodies in parallel, which increased the potential to detect statistically significant relationships between antibody features and protection,” says Saphire. “We used this global pool of antibodies to evaluate, and streamline, the research pipeline itself.”
In addition to identifying links between antibody target locations and activity, VIC researchers tested this huge pool of antibodies to reveal which antibodies “neutralized” the virus, why neutralization assays so often disagree, and whether or not neutralization in test tubes adequately predicted how well these antibodies would protect live animals from Ebola virus infection. Unexpectedly, neutralization alone was not always associated with the protective ability of an antibody.
Notably, the scientists found nine antibodies that protected mice from infection without neutralizing the virus in test tubes. These antibodies likely fight infection by interacting with an infected person’s immune system, helping orchestrate a better immune response to the virus.
This “immune effector” activity is featured in the team’s companion study published simultaneously in Cell Host & Microbe. “The ability to evoke an immune response will likely represent a new avenue of study for therapeutic antibodies for Ebola virus infection,” says Sharon Schendel, project manager for the VIC and science writer in the Saphire lab.
From the large body of results, VIC member and Scripps Research faculty member Kristian Andersen, PhD, and his graduate student Karthik Gangavarapu developed a network describing how each antibody feature correlates to protection, which can serve as a guide to predict whether newly identified antibodies will have therapeutic value. Saphire says the next steps for the VIC are to further test promising antibody cocktails in non-human primates. The team will also pursue engineering of antibodies that carry signature features to better drive immune system response.
Receive an email update when we add a new EBOLA article.
The Latest on: Ebola
via Google News
The Latest on: Ebola
Baby survives second deadliest Ebola outbreak
on December 16, 2018 at 10:16 am
A baby has recovered from what is now known as the world's second-deadliest Ebola outbreak. Baby Benedicte was admitted to an Ebola treatment center in the Democratic Republic of Congo, just six days ... […]
Congo Says Baby Girl Is Youngest Survivor of Ebola Outbreak
on December 16, 2018 at 4:35 am
JOHANNESBURG — Congo’s Health Ministry says a newborn baby called Benedicte is the youngest survivor of what is now the world’s second-deadliest Ebola outbreak. The ministry posted a photograph of the ... […]
Media and local messages on Ebola in the Grand Nord, DRC (November - December 2018)
on December 15, 2018 at 3:59 am
In comparing this collection of messages with those from 1-17 September 2018 (see previous SSHAP brief), several shifts in the content of local-level discussions around Ebola are evident. […]
“Young miracle” baby recovers from Ebola in outbreak
on December 14, 2018 at 10:06 pm
They call her the “young miracle.” A baby who was admitted to an Ebola treatment center just six days after birth has recovered from the virus. Congo’s health ministry called the baby the ... […]
Ebola outbreak reaches city of 1 million residents
on December 14, 2018 at 11:43 am
The Ebola outbreak in the Democratic Republic of the Congo has spread to a city of nearly 1 million residents. There are now 30 confirmed cases and 15 deaths in the city of Butembo reported in the ... […]
Youngest Ebola survivor brings hope to Congo caregivers
on December 14, 2018 at 11:38 am
(CNN) - The youngest survivor of the Ebola outbreak received her discharge certificate from the Beni Ebola Treatment Center on Wednesday, according to the Democratic Republic of Congo's Ministry of He... […]
Ebola-fighting protein discovered in human cells
on December 14, 2018 at 10:40 am
Researchers have discovered a human protein that helps fight the Ebola virus and could one day lead to an effective therapy against the deadly disease, according to a new study. The newly discovered a... […]
'Young miracle' newborn recovers from Ebola after mom dies in childbirth in world's 2nd deadliest outbreak
on December 14, 2018 at 10:15 am
A baby who was admitted to an Ebola treatment center in the eastern Democratic Republic of the Congo just six days after she was born is now recovered from the lethal virus, according to health ... […]
Top stories: Ebola outbreak challenges, Viking cats, and a new kind of placebo
on December 14, 2018 at 10:04 am
Concerns about an Ebola outbreak in the Democratic Republic of the Congo that surfaced in August are growing. Although communities seem to be responding well after more than 40,000 people received an ... […]
via Bing News